NCT07417033

Brief Summary

Knee Osteoarthritis (KOA) is commonly characterized by joint pain, swelling, stiffness, and a reduction in range of motion. These symptoms significantly affect daily activities and overall quality of life. A decrease in physical activity levels may further contribute to the deterioration of joint function over time. Physiotherapy assessment plays a critical role in the management of KOA. Such assessment enables a comprehensive evaluation of parameters including pain intensity, joint range of motion, muscle strength, flexibility, functional status, and quality of life. The use of both subjective and objective assessment methods is essential for developing individualized and effective treatment plans.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
2mo left

Started Feb 2024

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress91%
Feb 2024Jul 2026

Study Start

First participant enrolled

February 28, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2025

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

February 3, 2026

Completed
15 days until next milestone

First Posted

Study publicly available on registry

February 18, 2026

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2026

Expected
Last Updated

February 18, 2026

Status Verified

February 1, 2026

Enrollment Period

1 year

First QC Date

February 3, 2026

Last Update Submit

February 10, 2026

Conditions

Keywords

Knee OA specific functional outcome measures

Outcome Measures

Primary Outcomes (6)

  • Subjective Evaluation of the Knee Function 1

    Knee joint function will be evaluated using Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). Total score ranges from 0 to 96. Higher scores indicate worse pain and functional limitation..

    All tests will be performed at baseline.

  • Subjective Evaluation of the Knee Function 2

    Knee joint function will be evaluated using the Lequesne Algofunctional Knee Index. The index ranges from 0 to 24 points. Higher scores indicate greater pain and functional disability. The scale evaluates pain, maximum walking distance, and activities of daily living. A higher total score reflects a worse clinical condition.

    All tests will be performed at baseline.

  • Subjective Evaluation of the Knee Function 3

    Knee joint function will be evaluated using the Lysholm Knee Score.The score ranges from 0 to 100 points. Higher scores indicate better knee function and fewer symptoms. The scale assesses limp, support, locking, instability, pain, swelling, stair climbing, and squatting ability.

    All tests will be performed at baseline.

  • Objective Evaluation of the Knee Function 1

    Knee joint function will be evaluated using the 2-minute walk test. The test measures the maximum distance walked in two minutes, expressed in meters. A greater walking distance indicates better functional exercise capacity and mobility. There is no fixed maximum score, as results depend on the individual's performance.

    All tests will be performed at baseline.

  • Objective Evaluation of the Knee Function 2

    Knee joint function will be evaluated using the 30-second sit-to-stand test which is one of the objective measures.The test measures the number of full stands completed from a seated position in 30 seconds. Results are expressed as repetition count. A higher number of repetitions indicates better lower-extremity strength and functional mobility. There is no fixed maximum score, as performance depends on the individual.

    All tests will be performed at baseline.

  • Objective Evaluation of the Knee Function 3

    Knee joint function will be evaluated using the 9-step stair test.which is one of the objective measures.The test measures the time required to ascend and/or descend a flight of nine stairs, expressed in seconds. A shorter completion time indicates better functional mobility, balance, and lower-extremity performance. There is no fixed minimum or maximum score, as results depend on individual performance.

    All tests will be performed at baseline.

Study Arms (1)

Knee Osteoarthritis

Objective and Subjective Knee Evaluation Methods

Eligibility Criteria

Age45 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Participants diagnosed with Knee Osteoarthritis

You may qualify if:

  • Diagnosis of knee osteoarthritis at Kellgren-Lawrence Grade 2-3,
  • Age between 45 and 75 years,
  • A history of chronic knee pain lasting at least 6 months,
  • Absence of other diagnosed pathologies that could cause knee joint pain,
  • Willingness to participate in the study.

You may not qualify if:

  • Body mass index greater than 35 kg/m²,
  • A Lysholm Knee Score above 84,
  • A history of physiotherapy treatment or intra-articular injection within the previous 6 months,
  • A history of knee joint surgery,
  • The presence of a cardiorespiratory condition that would prevent the performance of functional tests,
  • The presence of a neuropsychiatric disorder that would interfere with the ability to follow instructions.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Lokman Hekim University

Ankara, Turkey (Türkiye)

Location

MeSH Terms

Conditions

OsteoarthritisPain

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
CASE CROSSOVER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assist. Prof.

Study Record Dates

First Submitted

February 3, 2026

First Posted

February 18, 2026

Study Start

February 28, 2024

Primary Completion

February 28, 2025

Study Completion (Estimated)

July 30, 2026

Last Updated

February 18, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Locations